Guangzhou Innogen Pharmaceutical Group Co Ltd

Company Profile

• Business description

  Guangzhou Innogen Pharmaceutical Group Co Ltd is a company in Asia to commercialize, a humanized, long-acting glucagon-like peptide-1 (GLP-1) receptor agonist. It has commercialized Efsubaglutide Alfa (brand name: Diabegone), its Core Product, for the treatment of type 2 diabetes (T2D) in China. Its core business model is to discover, develop and commercialize therapies for diabetes and other metabolic diseases. The company has built a pipeline of drug candidates namely YN014, YN401, YN209, YN202,YN203 targeting diabetes and other metabolic diseases.

• Contact

  No. 2 Tengfei Second Street
  Room 409, Building H Self-numbered Creative Building
  China-Singapore Guangzhou Knowledge City
  Huangpu District, Guangdong Province
  Guangzhou
  CHN

  https://www.innogenpharm.com

• Sector

  Healthcare

  Stock type

  Defensive

• Industry

  Biotechnology

  Fiscal Year End

  31 December 2026

  Employees

  193